Five years of local control of subscapularis aggressive fibromatosis managed by surgery and imatinib: a case report

INTRODUCTION: Imatinib, a tyrosine kinase inhibitor, is a major therapeutic option for the management of unresectable aggressive fibromatosis. Unfortunately, for most patients of low or very low average income countries, surgery often is the first treatment option. This is related to unavailability...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Med Case Rep
Auteurs principaux: Dao, Abou, Benchakroun, Nadia, Jabir, Hamza, Taleb, Amina, Bouchbika, Zineb, Tawfiq, Nezha, Jouhadi, Hassan, Sahraoui, Souha, Benider, Abdellatif
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2014
Sujets:
Case Report
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4307220/
https://ncbi.nlm.nih.gov/pubmed/25488584
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1752-1947-8-416
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires